Target intelligence / Profile preview

Clotting Factor Carboxylation Pathway

Molecular classification
Pathway, Post-translational modification
01

Overview

The clotting factor carboxylation pathway refers to the vitamin K-dependent post-translational modification of specific coagulation factors. This process is essential for the biological activity of these proteins, enabling them to bind calcium ions and participate effectively in the blood coagulation cascade. The central enzyme in this pathway is gamma-glutamyl carboxylase (GGCX), which catalyzes the addition of a carboxyl group to specific glutamic acid residues at the N-terminus of target proteins, converting them into gamma-carboxyglutamic acid residues. The main targets are several clotting factors: II (prothrombin), VII, IX, X, as well as regulatory proteins C, S, and Z. Gamma-carboxyglutamic acid residues enable these factors to bind calcium ions efficiently, allowing their association with phospholipid membranes.

02

Mechanism of action

Vitamin K antagonism, inhibition of vitamin K epoxide reductase

03

Biological functions

Blood coagulationHemostasisVitamin K metabolismCalcium binding
04

Disease associations

Bleeding disordersThrombosisVitamin K deficiency related diseases
05

Safety considerations

Bleeding riskDrug interactionsVitamin K deficiency
06

Interacting drugs

Warfarin

1 more in the full profile.

07

Biomarkers

Levels of undercarboxylated clotting factorsVitamin K levels

Beyond the preview

Go deeper on Clotting Factor Carboxylation Pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clotting Factor Carboxylation Pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call